Abstract
Recent advances now permit resection of many pharyngeal tumors through the open mouth, an approach that can greatly reduce the morbidity of surgical exposure. These transoral techniques are being rapidly adopted by the surgical community and hold considerable promise. On November 6-7, 2011, the National Cancer Institute sponsored a Clinical Trials Planning Meeting to address how to further investigate the use of transoral surgery, both in the good prognosis human papillomavirus (HPV)-initiated oropharyngeal cancers, and in those with HPV-unrelated disease. The proceedings of this meeting are summarized.
Copyright © 2012 Wiley Periodicals, Inc.
MeSH terms
-
Clinical Trials as Topic*
-
Combined Modality Therapy
-
Comorbidity
-
Congresses as Topic
-
Cost-Benefit Analysis
-
Head and Neck Neoplasms / economics
-
Head and Neck Neoplasms / epidemiology
-
Head and Neck Neoplasms / pathology
-
Head and Neck Neoplasms / therapy
-
Head and Neck Neoplasms / virology
-
Humans
-
Microsurgery
-
Neoplasm Recurrence, Local
-
Oropharyngeal Neoplasms / pathology
-
Oropharyngeal Neoplasms / prevention & control
-
Oropharyngeal Neoplasms / surgery
-
Oropharyngeal Neoplasms / therapy
-
Papillomavirus Infections / complications
-
Pharyngeal Neoplasms / pathology
-
Pharyngeal Neoplasms / prevention & control
-
Pharyngeal Neoplasms / surgery*
-
Pharyngeal Neoplasms / therapy
-
Quality of Life
-
Research Design
-
Robotics
-
Treatment Outcome